NASDAQ:CGEN

Compugen Stock Predictions

Healthcare > Biotechnology

Buy CGEN

*Your capital is at risk

$2.19

-0.0700 (-3.10%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CGEN Prediction Chart

CGEN Predictions History

Latest community submissions for CGEN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Alan Pro @Alan.115878	Jan 21, 2020	$6.19 -2.83%	$6.37	X	97.17%	1
PumpTheseNumbers Pro	Dec 12, 2019	$5.86 +4.64%	$5.60	X	95.36%	0
Alan Pro @Alan.115878	Dec 12, 2019	$6.00 +7.14%	$5.60	X	92.86%	0
Alan Pro @Alan.115878	Nov 26, 2019	$5.71 -1.55%	$5.80	X	98.45%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CGEN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT COMPUGEN LTD.

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by